We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300408:SZSEChaozhou Three-Circle (Group) Co., Ltd. Class A Analysis

Data as of 2026-03-16 - not real-time

CN¥55.06

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Chaozhou Three-Circle is trading at CNY 55.06, which sits above its 50‑day SMA (CNY 53.27) but below the 20‑day SMA (CNY 59.26), indicating a short‑term pull‑back within an overall bullish trend. The RSI of 45.9 suggests neutral momentum, while the MACD histogram remains negative, giving a bearish signal and the volume trend is decreasing, hinting at weakening short‑term buying pressure. Valuation metrics are stretched: the forward PE of 31.5 and trailing PE of 41.7 far exceed the industry average PE of 34.2, and the DCF‑derived fair value of CNY 24.24 implies the stock is priced at a ~56% premium to intrinsic value. Fundamentally, the company is robust with 20.8% revenue growth, gross margin of 42.3%, operating margin of 30.9%, and a healthy ROE of 12.6%; cash on hand (CNY 7.94 bn) dwarfs total debt (CNY 0.59 bn), supporting dividend sustainability at a modest 0.69% yield.
The stock exhibits high 30‑day volatility (≈67%) but a low beta of 0.33, indicating limited systematic risk. Sector‑specific risks are moderate given the technology and electronic components exposure in China, where regulatory scrutiny can be heightened. Overall, the price reflects strong optimism, yet the discrepancy between market price and intrinsic valuation suggests caution, making the stock more suitable for investors with a longer horizon who can tolerate short‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical resistance and below short‑term SMA
  • Bearish MACD histogram and decreasing volume
  • Significant valuation premium to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and high operating margins
  • Robust cash position offsetting modest debt levels
  • Valuation gap may compress as market reassesses fundamentals

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained earnings growth and solid ROE
  • Low leverage with ample cash reserves
  • Strategic positioning in high‑growth sectors like new energy and medical ceramics

Key Metrics & Analysis

Financial Health

Revenue Growth20.80%
Profit Margin29.94%
P/E Ratio41.7
ROE12.62%
ROA5.73%
Debt/Equity2.81
P/B Ratio5.0
Op. Cash FlowCN¥2.9B
Free Cash FlowCN¥1.2B
Industry P/E34.2

Technical Analysis

TrendBullish
RSI45.9
SupportCN¥50.81
ResistanceCN¥68.86
MA 20CN¥59.26
MA 50CN¥53.27
MA 200CN¥43.64
MACDBearish
VolumeDecreasing
Fear & Greed Index79.09

Valuation

Fair ValueCN¥24.24
Target PriceCN¥54.75
Upside/Downside-0.56%
GradeOvervalued
TypeBlend
Dividend Yield0.69%

Risk Assessment

Beta0.33
Volatility67.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.